Optimal Therapy of Growth Hormone Deficiency in the Child and Adolescent physiological pattern of GH secretion; • development of alternative delivery systems; and • improvement of the transition process from paediatric to adult care.
Theoretically, future developments in treatment of the child with GHD might include therapies that are currently difficult to imagine, such as gene therapy to re-establish GH secretion, placental transplantation to supply chorionic somatomammotropin (in place of
1. Hardin DS, Woo J, Butsch R, Huett B, Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists, Clin Endocrinol (Oxf), 2007;66:85–94.
2. Grumbach MM, Bin-Abbas BS, Kaplan SL, The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency, Horm Res, 1998;49(Suppl. 2):41–57.
3. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, et al., Improvements in final height over 25 years in growth hormone (GH)- deficient childhood survivors of brain tumors receiving GH replacement, J Clin Endocrinol Metab, 2003;88:3682–9.
4. Wilson TA, Rose SR, Cohen P, et al., Update of guidelines for the use of growth hormone in children: The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee, J Pediatr, 2003;143:415–21.
5. Richmond E, Rogol AD, Current indications for growth hormone therapy for children and adolescents, Endocr Dev, 2010;18:92–108.
6. Juul A, Bernasconi S, Clayton PE, et al., Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency, Horm Res, 2002;58:233–41.
7. Rose SR, Vogiatzi MG, Copeland KC, A general pediatric approach to evaluating a short child, Pediatrics in Review, 2005;26:410–20.
8. Högler W, Shaw N, Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence, Clin Endocrinol (Oxf), 2010;72:281–9.
9. Cowell CT, Woodhead HJ, Brody J, Bone markers and bone mineral density during growth hormone treatment in children with growth hormone deficiency, Horm Res, 2000;54(Suppl.1):44–51.
10. Decker R, Albertsson-Wikland K, Kriström B, et al., Metabolic outcome of GH treatment in prepubertal short children with and without classical GH-deficiency, Clin Endocrinol (Oxf), 2010;73(3):346–54.
11. Widdowson WM, Gibney J, The effect of growth hormone replacement on exercise capacity in patients with GH deficiency: a metanalysis, J Clin Endocrinol Metab, 2008;93:4413–7.
12. Stochholm K, Gravholt CH, Socio-economic parameters in adults with childhood onset growth hormone deficiency, Presented at: the Endocrine Society 92nd Annual Meeting, San Diego, US, 19–22 June, 2010:P2–360.
13. Root AW, Root MJ, Clinical pharmacology of human growth hormone and its secretagogues, Curr Drug Targets Immune Endocr Metabol Disord, 2002;2:27–52.
14. Bluet-Pajot MT, Tolle V, Zizzari P, et al., Growth hormone secretagogues and hypothalamic networks, Endocrine, 2001;14:1–8.
15. Camiña JP, Carreira MC, Micic D, et al,. Regulation of ghrelin secretion and action, Endocrine, 2003;22:5–12.
16. Wagner C, Caplan SR, Tannenbaum GS, Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model, J Mol Endocrinol, 2009;43:105–19.
17. Ionescu M, Frohman LA, Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog, J Clin Endocrinol Metab, 2006;91:4792–7.
18. Rose SR, Municchi G, Barnes KM, et al., Spontaneous growth hormone secretion increases during puberty in normal girls and boys, J Clin Endocrinol Metab, 1991;73:428–35.
19. Rose SR, Municchi G, Six-hour and four-hour nocturnal sampling for growth hormone, J Pediatr Endocrinol Metab, 1999;12:167–73.
20. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F, An amplitude-specific divergence in the pulsatile mode of growth hormone secretion underlies the gender difference in mean GH concentrations in men and premenopausal women, J Clin Endocrinol Metab, 1996;81:2460–7.
21. Rose SR, Baron J, Bernstein D, et al, Suppression and recovery of GH secretion after GH injection in non-GH- deficient short children, J Pediatr Endocrinol Metab, 2000;13:281–8.
22. Gelato MC, Malozowski S, Nicoletti MC, et al, Growth hormone responses to growth-hormone releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and growth hormone deficiency, J Clin Endocrinol Metab, 1986;63:174–9.
23. Smyczynska J, Hilczer M, Stawerska R, Lewinski A, Thyroid function in children with growth hormone (GH) deficiency
GH), long-term oral GHRP, or a year-long depot GH-releaser that would allow continuing pulsatile GH release. Of note, these speculations are not based on literature evidence. The primary focus of this review has been to address how to optimise therapy for paediatric patients who have GHD. Once the decision has been made to treat a child with GH, therapy should be administered in a way that yields the best growth response with the best safety profile and the best psychosocial adjustment. n
during the initial phase of GH replacement therapy – clinical implications, Thyroid Res, 2010;3:2.
24. Desrosiers P, O’Brien F, Blethen S, Patient outcomes in the GHMonitor: the effect of delivery device on compliance and growth, Pediatr Endocrinol Rev, 2005;2(Suppl. 3):327–31.
25. Sandberg DE, MacGillivray MH, Growth hormone therapy in childhood-onset growth hormone deficiency: adult anthropometric and psychological outcomes, Endocrine, 2000;12:173–82.
26. Lagrou K, Xhrouet-Heinrichs D, Massa G, et al., Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency, J Pediatr Endocrinol Metab, 2001;14(Suppl. 5):1249–62.
27. Bell J, Parker KL, Swinford RD, et al., Long-term safety of recombinant human growth hormone in children, J Clin Endocrinol Metab, 2010;95:167–77.
28. Sas TC, de Ridder MA, Wit JM, et al., Adult height in children with growth hormone deficiency: A randomized, controlled, growth hormone dose-response trial, Horm Res Paediatr, 2010;74(3):172–81.
29. Bakker B, Frane J, Anhalt H, et al., Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children, J Clin Endocrinol Metab, 2008;93:352–7.
30. Mauras N, Attie KM, Reiter EO, et al., High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group, J Clin Endocrinol Metab, 2000;85:3653–60.
31. Ranke MB, Clinical considerations in using growth hormone therapy in growth hormone deficiency, Endocr Dev, 2010;18:83–91.
32. Ranke MB, Lindberg A, Chatelain P, et al., Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study, J Clin Endocrinol Metab, 1999;84:1174–83.
33. de Ridder MA, Stijnen T, Hokken-Koelega AC, Prediction of adult height in growth-hormone-treated children with growth hormone deficiency, J Clin Endocrinol Metab, 2007;92:925–31.
34. Cook DM, Ludlam WH, Cook MB, Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults, J Clin Endocrinol Metab, 1999; 84:3956–60.
35. Rose SR, Shulman DI, Larsson P, et al., Gender does not influence prepubertal growth velocity during growth hormone therapy—Analysis of United States KIGS data, J Pediatr Endocrinol Metab, 2005;18:1045–51.
36. Ross J, Lee PA, Gut R, Germak J, Factors influencing the one- and two-year growth response in children treated with growth hormone: Analysis from an observational study, Int J Pediatr Endocrinol, 2010; (Epub ahead of print).
37. Kemp SR, Kuntze J, Attie KM, et al., Efficacy and safety results of lon-term growth hormone treatment of idiopathic short stature, J Clin Endocrinol Metab, 2005;90:5247–53.
38. Carel JC, Ecosse E, Nicolina M, et al., Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: Observational follow up study of the French population based registry, Br Med J, 2002;325:370.
39. Cohen P, Germak J, Rogol AD, et al., Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children, J Clin Endocrinol Metab, 2010;95:2089–98.
40. Cohen P, Rogol AD, Howard CP, et al., Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study, J Clin Endocrinol Metab, 2007;92:2480–6.
41. Kriström B, Aronson AS, Dahlgren J, et al., Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature, J Clin Endocrinol Metab, 2009;94:483–90.
42. Kreitschmann-Andermahr I, Poll EM, Reineke A, et al., Growth hormone deficient patients after traumatic brain injury—baseline characteristics and benefits after growth hormone replacement—an analysis of the German KIMS database, Growth Horm IGF Res, 2008;18:472–8.
43. Mulder RL, Kremer LC, van Santen HM, et al., Prevalence and
risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review, Cancer Treat Rev, 2009;35:616–32.
44. Darzy KH, Radiation-induced hypopituitarism after cancer therapy: who, how and when to test, Nat Clin Pract Endocrinol Metab, 2009;5:88–99.
45. Rose SR, Endocrinopathies after childhood cancer, The Endocrinologist, 2003;13:488–95.
46. Kaulfers AMD, Backeljauw PF, Blum S, et al., Traumatic brain injury in children: Endocrine sequelae, J Pediatr, 2010;157(6):894–9.
47. Ghigo E, Masel B, Aimaretti G, et al., Consensus guidelines on screening for hypopituitarism following traumatic brain injury, Brain Inj, 2005;19:711–24.
48. Smith SL, Hindmarsh PC, Brook CG, Compliance with growth hormone treatment—are they getting it?, Arch Dis Child, 1993;68:91–3.
49. Hamilton JG, Needle phobia: a neglected diagnosis, J Fam Pract, 1995;41:169–75.
50. Aguiar-Oliveira MH, Meneguz-Moreno RA, Nascimento-Junior AC, New options and preparations in growth hormone therapy, Arq Bras Endocrinol Metabol, 2008;52:917–24.
51. Fuchs GS, Mikkelsen S, Knudsen TK, Kappelgaard AM, Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test, Clin Ther, 2009;31:2906–14.
52. Beckers D, Thomas M, Jamart J, et al., Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience, Eur J Endocrinol, 2010;162:483–90.
53. Mauras N, Bishop K, Welch S, Growth hormone action in puberty: Effects by gender, Growth Horm IGF Res, 2007;17:463–71.
54. Rosenfeld RG, The future of research into growth hormone responsiveness, Horm Res, 2009;71(Suppl. 2):71–4.
55. Jorge AA, Marchisotti FG, Montenegro LR, et al, Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency, J Clin Endocrinol Metab, 2006;91:1076–80.
56. Ranke MB, Lindberg A, KIGS International Board, Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables, J Clin Endocrinol Metab, 2010;95:1229–37.
57. Albertsson Wikland K, Alm F, Aronsson S, et al., Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens, Acta Paediatr Suppl, 1999;88:80–4.
58. Buzi F, Mella P, Pilotta A, et al., Growth hormone receptor polymorphisms, Endocr Dev, 2007;11:28–35.
59. Drake WM, Howell SJ, Monson JP, Shalet SM, Optimizing gh therapy in adults and children, Endocr Rev, 2001;22:425–50.
60. Wassenaar MJ, Dekkers OM, Pereira AM, et al., Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis, J Clin Endocrinol Metab, 2009;94:3721–30.
61. Land C, Blum WF, Shavrikova E, et al., Predicting the growth response to growth hormone (GH) treatment in prepubertal and pubertal children with isolated GH deficiency—model validation in an observational setting (GeNeSIS), J Pediatr Endocrinol Metab, 2007;20:685–93.
62. Kriström B, Dahlgren J, Niklasson A, et al., The first-year growth response to growth hormone treatment predicts the long-term prepubertal growth response in children, BMC Med Inform Decis Mak, 2009;9:1.
63. Chatelain P, Tato L, Peterkova V, et al., Relationship between1-month biomarker changes and 1-year growth response in prepubertal children with growth hormone deficiency or Turner syndrome treated for 1 year with GH: The PREDICT multicentre, observational follow-up study, Presented at: the Endocrine Society 92nd Annual Meeting, San Diego, US, 19–22 June, 2010: P1–677.
64. Reiter EO, Price DA, Wilton P, et al., Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database, J Clin Endocrinol Metab, 2006;91:2047–54.
65. Maghnie M, Ambrosini L, Cappa M, et al., Adult height in patients with permanent growth hormone deficiency with and without multiple pituitary hormone deficiencies,
EUROPEAN ENDOCRINOLOGY 45
| Page 2
| Page 3
| Page 4
| Page 5
| Page 6
| Page 7
| Page 8
| Page 9
| Page 10
| Page 11
| Page 12
| Page 13
| Page 14
| Page 15
| Page 16
| Page 17
| Page 18
| Page 19
| Page 20
| Page 21
| Page 22
| Page 23
| Page 24
| Page 25
| Page 26
| Page 27
| Page 28
| Page 29
| Page 30
| Page 31
| Page 32
| Page 33
| Page 34
| Page 35
| Page 36
| Page 37
| Page 38
| Page 39
| Page 40
| Page 41
| Page 42
| Page 43
| Page 44
| Page 45
| Page 46
| Page 47
| Page 48
| Page 49
| Page 50
| Page 51
| Page 52
| Page 53
| Page 54
| Page 55
| Page 56
| Page 57
| Page 58
| Page 59
| Page 60
| Page 61
| Page 62
| Page 63
| Page 64
| Page 65
| Page 66
| Page 67
| Page 68